Composition for the sustained and controlled release of medicamentous substances and a process for preparing the same

Claim 2

A sustained and controlled release composition consisting essentially of microspheres of biodegradable polymeric material which incorporate therein a water-insoluble salt of a medicamentous peptide substance having the formula (I): Ac-D-Nal-D-pClPhe-R.sup.3 -Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH.sub.2(I) wherein R 3 is D-Pal or D-Trp.

Claim 3

Composition according to claim 1, wherein the water-insoluble peptide is a pamoate, tannate, stearate or palmitate.

Claim 4

Composition according to claim 1, wherein the biodegradable polymeric material is a polylactide, a polyglycolide or a copolymer of lactic and glycolic acids.

Claim 5

Composition according to claim 1, wherein the copolymer of lactic and glycolic acids is a copolymer of L- or D,L-lactic acid containing from 45 to 90% (molar) of lactic acid units and respectively 55 to 10% (molar) of glycolic acid units.

Claim 6

Composition according to one of claims 1 in the form of microspheres of a 75:25 (molar %) copolymer of lactic and glycolic acids, including at least 5% in weight of the pamoate salt of a peptide of formula (I).

Claim 7

A sustained and controlled release composition consisting essentially of micropheres of a biodegradable polymeric material which incorporate therein a water-insoluble salt of a medicamentous peptide substance having the formula (I): Ac-D-Nal-D-pClPhe-R.sub.3 -Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH.sub.2(I) wherein R 3 is D-Pal or D-Trp, said composition prepared by process comprising the steps of: a) converting a water-soluble peptide salt of formula (I) into a water-insoluble peptide salt; b) suspending said water-insoluble peptide salt in an organic medium containing the biodegradable polymeric material in the dissolved state to afford an organic suspension; c) dispersing said organic suspension in an aqueous medium which forms the continuous phase of the resulting emulsion, said aqueous medium consisting essentially of water; d) transferring said emulsion into an excess of an aqueous medium; and e) separating microspheres thus obtained from the liquid phase, said microspheres containing a pharmaceutically effective amount between about 5-20% by weight of said water-insoluble peptide salt.

Claim 8

A sustained and controlled release composition consisting essentially of micropheres of a biodegradable polymeric material which incorporate therein a water-insoluble salt of a medicamentous peptide substance having the formula (I): Ac-D-Nal-D-pClPhe-R.sub.3 -Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH.sub.2(I) wherein R 3 is D-Pal or D-Trp, said composition prepared by process comprising the steps of: a) converting a water-soluble peptide salt of formula (I) into a water-insoluble peptide salt; b) suspending said water-insoluble peptide salt in an organic medium containing the biodegradable polymeric material in the dissolved state to afford an organic suspension; c) dispersing said organic suspension in an aqueous medium which forms the continuous phase of the resulting emulsion, said aqueous medium consisting essentially of water; d) transferring said emulsion into an excess of an aqueous medium; and e) separating microspheres thus obtained from the liquid phase, said microspheres containing a pharmaceutically effective amount between about 5-20% by weight of said water-insoluble peptide salt.

Claim 9

Composition according to claim 1, wherein before the transfer of the oil-in-water emulsion into an excess of aqueous medium, a partial evaporation of the organic solvent forming the oil phase is carried out.

Claim 10

Composition according to claim 1, wherein the water-insoluble peptide salt is a pamoate, a tannate, a stearate or a palmitate.

Claim 11

Composition according to one of claim 1, wherein the biodegradable polymeric material is a polylactide, a polyglycolide, or a copolymer of lactic and glycolic acids.

Claim 12

Composition according to claim 1, wherein the copolymer of lactic and glycolic acids is a copolymer of L- or D,L-lactic acid containing from 45 to 90% (molar) of lactic acid units and respectively 55 to 10% (molar) of glycolic acid units.

Claim 13

Process according to claim 6, wherein the water-insoluble peptide salt is present in the microspheres in an amount of from about 5% by weight.

Claim 14

The composition of claim 6, wherein said aqueous medium additionally contains a surfactant.

Claim 15

A sustained and controlled release composition consisting essentially of microspheres of a biodegradable polymeric material which incorporate therein a water-insoluble salt of a medicamentous peptide substance, said water-insoluble salt having a water solubility less than or equal to 0.1 mg/ml at 25° C., said peptide substance having the formula (I): Ac-D-NAl-D-pClPhe-R.sup.3 -Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH.sub.2(I), wherein R 3 is D-Pal or D-Trp and said biodegradable polymeric material being a polylactide, a polyglycolide, or a copolymer of lactic and glycolic acids, said composition prepared by a process comprising the steps of: a) converting a water-soluble peptide salt of formula (I) into a water-insoluble peptide salt; b) suspending said water-insoluble peptide salt in an organic medium containing the biodegradable polymeric material in the dissolved state to afford an organic suspension; c) dispersing said organic suspension in an aqueous medium which forms the continuous phase of the resulting emulsion, said aqueous medium consisting essentially of water and a surfactant; d) transferring said emulsion into an excess of an aqueous medium; and e) separating microspheres thus obtained from the liquid phase, said microspheres containing a pharmaceutically effective amount between about 5-20% by weight of said water-insoluble peptide salt.

Claim 16

A sustained and controlled release composition consisting essentially of microspheres of a biodegradable polymeric material which incorporate therein a water-insoluble salt of a medicamentous peptide substance, said water-insoluble salt having a water solubility less than or equal to 0.1 mg/ml at 25° C., said peptide substance having the formula (I): Ac-D-NAl-D-pClPhe-R.sup.3 -Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH.sub.2(I), wherein R 3 is D-Pal or D-Trp and said biodegradable polymeric material being a polylactide, a polyglycolide, or a copolymer of lactic and glycolic acids, said composition prepared by a process comprising the steps of: a) converting a water-soluble peptide salt of formula (I) into a water-insoluble peptide salt; b) suspending said water-insoluble peptide salt in an organic medium containing the biodegradable polymeric material in the dissolved state to afford an organic suspension; c) dispersing said organic suspension in an aqueous medium which forms the continuous phase of the resulting emulsion, said aqueous medium consisting essentially of water and a surfactant; d) transferring said emulsion into an excess of an aqueous medium; and e) separating microspheres thus obtained from the liquid phase, said microspheres containing a pharmaceutically effective amount between about 5-20% by weight of said water-insoluble peptide salt.

Claim 17

The composition of claim 13, wherein said copolymer of lactic and glycolic acids is a copolymer of L- or D,L-lactic acid containing from 45 to 90% (molar) of lactic acid units and respectively 55 to 10% (molar) of glycolic acid units.